Does MOGAMULIZUMAB Cause Hepatitis b? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hepatitis b have been filed in association with MOGAMULIZUMAB (POTELIGEO). This represents 1.4% of all adverse event reports for MOGAMULIZUMAB.
6
Reports of Hepatitis b with MOGAMULIZUMAB
1.4%
of all MOGAMULIZUMAB reports
4
Deaths
1
Hospitalizations
How Dangerous Is Hepatitis b From MOGAMULIZUMAB?
Of the 6 reports, 4 (66.7%) resulted in death, 1 (16.7%) required hospitalization.
Is Hepatitis b Listed in the Official Label?
Yes, Hepatitis b is listed as a known adverse reaction in the official FDA drug label for MOGAMULIZUMAB.
What Other Side Effects Does MOGAMULIZUMAB Cause?
Rash (59)
Disease progression (46)
Infusion related reaction (42)
Pyrexia (35)
Febrile neutropenia (29)
Erythema (28)
Pruritus (26)
Drug ineffective (24)
Constipation (22)
Death (21)
What Other Drugs Cause Hepatitis b?
RITUXIMAB (597)
CYCLOPHOSPHAMIDE (578)
LAMIVUDINE (480)
DOXORUBICIN (469)
VINCRISTINE (431)
PREDNISOLONE (371)
TENOFOVIR DISOPROXIL (257)
PREDNISONE (208)
DEXAMETHASONE (173)
ENTECAVIR (166)
Which MOGAMULIZUMAB Alternatives Have Lower Hepatitis b Risk?
MOGAMULIZUMAB vs MOGAMULIZUMAB-KPKC
MOGAMULIZUMAB vs MOLNUPIRAVIR
MOGAMULIZUMAB vs MOLSIDOMINE
MOGAMULIZUMAB vs MOMELOTINIB
MOGAMULIZUMAB vs MOMETASONE